BioTechX 2024 panel discussion ONTOFORCE AstraZeneca Novo Nordisk

Video

GenAI for drug development: data, expertise, systems

BioTechX 2024 panel discussion

9 October 2024, Basel  
BioTechX panel discussion

In this insightful panel talk, experts from the fields of AI, life sciences, and pharmaceuticals converge to explore the potent intersection of GenAI and drug discovery. With a primary focus on leveraging data assets, optimizing human expertise, and refining computational systems, the discussion dives deeper into the opportunities and hurdles in the development of artificial intelligence.

This discussion took place on 9 October, 2024 at BioTechX Europe in Basel. BioTechX Europe brings together pharma, academia, and clinicians to showcase innovation and foster meaningful collaborations across the field.

Panel members

Allan Christian Shaw  Corporate Vice President at Novo Nordisk   ONTOFORCE

Allan Christian Shaw

Corporate Vice President,

Data & Knowledge Discovery 

Novo Nordisk

Mathew Woodwark Astra Zeneca ONTOFORCE

Mathew Woodwark

Head of Data Standards and Interoperability, R&D Data Office

AstraZeneca

Michel Dumontier

Michel Dumontier

Distinguished Professor and

co-founder of FAIR

Universiteit Maastricht

Bérénice Wulbrecht - VP Solution Enablement ONTOFORCE

Bérénice Wulbrecht

Moderator
VP Solutions Enablement
ONTOFORCE

Watch the recording